Improving the management of acute myocardial infarction.
作者信息
Savage Mark W, Channer Kevin S
出版信息
BMJ. 2002 Nov 23;325(7374):1185-6. doi: 10.1136/bmj.325.7374.1185.
Abstract
摘要
相似文献
1
Improving the management of acute myocardial infarction.改善急性心肌梗死的管理。
BMJ. 2002 Nov 23;325(7374):1185-6. doi: 10.1136/bmj.325.7374.1185.
2
Local logistics guided management of acute ST elevation myocardial infarction: need of the hour.急性ST段抬高型心肌梗死的本地物流引导式管理：当下之需
J Indian Med Assoc. 2009 Sep;107(9):601-2.
3
Thrombolytic therapy in acute myocardial infarction.
Nurs Stand. 2005;19(37):55-64; quiz 66. doi: 10.7748/ns2005.05.19.37.55.c3878.
4
2004 ACC/AHA guideline for the management of patients with STEMI: the implications for clinicians.2004年美国心脏病学会/美国心脏协会ST段抬高型心肌梗死患者管理指南：对临床医生的启示
Nat Clin Pract Cardiovasc Med. 2005 Mar;2(3):114-5. doi: 10.1038/ncpcardio0135.
5
Coronary care unit and primary percutaneous coronary intervention networks improve the standard of care: reperfusion therapy in ST elevation myocardial infarction in Serbia from 2002 to 2008.
J Cardiovasc Med (Hagerstown). 2011 Apr;12(4):300-2. doi: 10.2459/JCM.0b013e328343e9f2.
6
Primary PCI or pharmaco-invasive strategy in ST-segment elevation myocardial infarction.
Int J Cardiol. 2014 Apr 1;172(3):e409-10. doi: 10.1016/j.ijcard.2013.12.256. Epub 2014 Jan 10.
7
Thrombolytic therapy for acute myocardial infarction.急性心肌梗死的溶栓治疗
Postgrad Med. 1991 Nov 1;90(6):52-6, 61-2, 65-7. doi: 10.1080/00325481.1991.11701100.
8
Acute myocardial infarction: treatment with thrombolytic therapy.急性心肌梗死：溶栓治疗
Cardiol Clin. 1989 Nov;7(4):827-36.
9
Viewpoint: thrombolysis or angioplasty in the real world: a UK perspective.
Circulation. 2006 Jun 13;113(23):f89-91.
10
Domiciliary thrombolytic treatment.家庭溶栓治疗。
BMJ. 1991 Jul 13;303(6794):120.
引用本文的文献
1
Checklists for myocardial infarction should be precise.心肌梗死的检查表应该精确。
BMJ. 2003 Feb 22;326(7386):448. doi: 10.1136/bmj.326.7386.448/b.
本文引用的文献
1
Safety and efficacy of nurse initiated thrombolysis in patients with acute myocardial infarction.护士启动的溶栓治疗在急性心肌梗死患者中的安全性和有效性。
BMJ. 2002 Jun 1;324(7349):1328-31. doi: 10.1136/bmj.324.7349.1328.
2
Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial.初始心肺复苏未成功后溶栓治疗的疗效和安全性：一项前瞻性临床试验。
Lancet. 2001 May 19;357(9268):1583-5. doi: 10.1016/S0140-6736(00)04726-7.
3
Strict reliance on a computer algorithm or measurable ST segment criteria may lead to errors in thrombolytic therapy eligibility.严格依赖计算机算法或可测量的ST段标准可能会导致溶栓治疗资格判断出现错误。
Am Heart J. 2000 Aug;140(2):221-6. doi: 10.1067/mhj.2000.108240.
4
Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.
Circulation. 2000 May 16;101(19):2239-46. doi: 10.1161/01.cir.101.19.2239.
5
Reperfusion therapy for acute myocardial infarction: observations from the National Registry of Myocardial Infarction 2.急性心肌梗死的再灌注治疗：来自心肌梗死国家注册登记2的观察结果
Cardiol Rev. 1999 May-Jun;7(3):156-60. doi: 10.1097/00045415-199905000-00013.
6
Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study.入院时的糖代谢状态：常规治疗的糖尿病合并急性心肌梗死患者死亡率的重要风险标志物：急性心肌梗死糖尿病与胰岛素 - 葡萄糖输注（DIGAMI）研究的长期结果
Circulation. 1999 May 25;99(20):2626-32. doi: 10.1161/01.cir.99.20.2626.
7
Perceived contraindications to thrombolytic treatment in acute myocardial infarction. A survey at a teaching hospital.急性心肌梗死溶栓治疗的认知禁忌证。一家教学医院的调查。
J Accid Emerg Med. 1998 Sep;15(5):329-31. doi: 10.1136/emj.15.5.329.
8
ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.ISIS-2研究：疑似急性心肌梗死患者在静脉注射链激酶、口服阿司匹林、两者联合或两者均不用的随机对照试验中的10年生存率。ISIS-2（第二项心肌梗死生存国际研究）协作组
BMJ. 1998 May 2;316(7141):1337-43. doi: 10.1136/bmj.316.7141.1337.
9
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.糖尿病视网膜病变不应成为急性心肌梗死溶栓治疗的禁忌证：对GUSTO-I试验中眼内出血发生率及部位的回顾。全球应用链激酶和组织型纤溶酶原激活剂治疗冠状动脉闭塞。
J Am Coll Cardiol. 1997 Dec;30(7):1606-10. doi: 10.1016/s0735-1097(97)00394-x.
10
Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies.急性心肌梗死溶栓治疗的最佳应用：概念与争议
J Am Coll Cardiol. 1990 Jul;16(1):223-31. doi: 10.1016/0735-1097(90)90482-5.
Zotero 插件